HTA18 First to launch, first to falter?: an investigation into the clinical benefits and HTA outcomes for first-in-class drugs
Civitelli, D.
, Politopoulou, K., Mills, M. & Kanavos, P.
(2024).
HTA18 First to launch, first to falter?: an investigation into the clinical benefits and HTA outcomes for first-in-class drugs.
Value in Health,
27(12, Supplement), S356 - S356.
https://doi.org/10.1016/j.jval.2024.10.1843
, Politopoulou, K., Mills, M. & Kanavos, P.
(2024).
HTA18 First to launch, first to falter?: an investigation into the clinical benefits and HTA outcomes for first-in-class drugs.
Value in Health,
27(12, Supplement), S356 - S356.
https://doi.org/10.1016/j.jval.2024.10.1843